• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • News: Health

    How to aid the fight against Asia-Pacific's 'silent killer'

    Viral hepatitis remains on the fringes of the development agenda. But while HIV and AIDS, malaria and tuberculosis take the spotlight, the disease continues to kill over a million people each year — and that's just in Asia-Pacific. A regional advocacy group suggests how to move forward.

    By Lean Alfred Santos // 17 March 2014
    A nurse gives a Hepatitis B vaccination to a patient at the Korea-Afghanistan Friendship Medical Center in Parwan, Afghanistan. Asia-Pacific is vulnerable to viral hepatitis, with 74 percent of all the people infected with hepatitis B. Photo by: Sarah Martinez / NATO Training Mission-Afghanistan / CC BY-SA

    Despite global health's remarkable progress over the last few years, particularly in medicine and treatment, the rise and persistence of an increasingly resistant and viral disease continue to stunt Asia-Pacific’s development.

    Unlike HIV and AIDS, malaria or tuberculosis — which have been subjects of major aid programs —  viral hepatitis still remains largely trapped in the shadows of the post-2015 agenda.

    Large-scale initiatives to combat this infection of the liver that can be fatal if left untreated still lack the necessary push despite affecting over 500 million people worldwide, and this why an international advocacy group is calling for not just more money but a new funding mechanism for prevention and treatment.

    “The last decade has witnessed significant breakthroughs in the development of effective medicines for chronic hepatitis ... [but] only half of the countries in Asia-Pacific make publicly-funded treatment available,” Stephen Locarnini, secretary of the Coalition to Eradicate Viral Hepatitis in Asia-Pacific, told Devex. “Funding issues present a significant barrier to the ability of governments to implement lasting measures to reduce the burden of disease.”

    He added: “[We] believe an international funding mechanism is urgently needed to support efforts to combat viral hepatitis in low income countries... We are urging the international donor community as well as multilateral humanitarian NGOs to step forward and join the efforts.”

    Asia-Pacific is particularly vulnerable to the disease, with 74 percent of all people infected with hepatitis (B) — often transmitted through blood-to-blood contact or unsafe intercourse — living in the region, where over a million people die every year from the disease.

    Putting more focus

    Unlike HIV, malaria and tuberculosis, viral hepatitis remains on the fringes of development discussions.

    An regional alliance has been established along with a trust fund to fight and eradicate malaria, while the Global Fund was established to combat the previous three diseases globally.

    Locarnini admitted that the fight to prevent and eradicate viral hepatitis is still in its “infancy stage”, making it clear the disease is “not receiving the same level of attention, resources or investment in cross-sector partnerships,” and highlighting the need to put more focus to the issue.

    Intentions to seriously address the disease are there — in particular with the creation of an independent viral hepatitis unit within the World Health Organization — but more needs to be done and that is action and collaboration.

    “The global response has built momentum, but to date, action in [the region] has largely been slow and uncoordinated, with very few cross-sector partnerships to support national or regional efforts to combat viral hepatitis,” the CEVHAP official said. “It's important to address viral hepatitis from both [regional and national] perspectives,” Locarnini noted.

    Role of aid

    Only half — or even less — of Asia-Pacific governments have national strategies for addressing hepatitis, with the majority coming from the low- and middle-income categories — and that's where much more help is needed.

    “The aid and development community are critically important to the fight to eradicate viral hepatitis in Asia Pacific. One of the major barriers to combating viral hepatitis is the fact that the highest disease burden is often found in countries that can least afford the resources needed to tackle these disease,” Locarnini explained.

    He concluded: “In some countries this is a reflection of the need for strengthened technical assistance, but for many low- and middle-income countries it is symptomatic of the fact that funding remains the largest barrier to the strengthening of public policy.”

    “Cross-sector partnerships are crucially important to mobilizing expertise but also to unlocking the resources needed to tackle viral hepatitis.”

    Infographic by CEVHAP. Click here to view the larger version.

    Read more development aid news online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.

    • Global Health
    • Funding
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Lean Alfred Santos

      Lean Alfred Santos@DevexLeanAS

      Lean Alfred Santos is a former Devex development reporter focusing on the development community in Asia-Pacific, including major players such as the Asian Development Bank and the Asian Infrastructure Investment Bank. He previously covered Philippine and international business and economic news, sports and politics.

    Search for articles

    Related Stories

    FinanceNew ADB platform aims to help end malaria, TB, and dengue in Asia-Pacific

    New ADB platform aims to help end malaria, TB, and dengue in Asia-Pacific

    Global HealthUS funding cuts risk spread of hepatitis

    US funding cuts risk spread of hepatitis

    Global healthHow Trump’s aid freeze is threatening tuberculosis programs

    How Trump’s aid freeze is threatening tuberculosis programs

    Global HealthWe know how to treat anemia. So why is it still so common?

    We know how to treat anemia. So why is it still so common?

    Most Read

    • 1
      The power of diagnostics to improve mental health
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      Opinion: Urgent action is needed to close the mobile gender gap
    • 4
      The UN's changing of the guard
    • 5
      The top local employers in Europe
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement